+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains



Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains



Infection and Immunity 68(1): 192-196



Chlamydia trachomatis is a major cause of sexually transmitted disease (STD) for which a vaccine is needed. CD4(+) T-helper type 1 (Th1) cell-mediated immunity is an important component of protective immunity against murine chlamydial genital infection. Conventional vaccine approaches have not proven effective in eliciting chlamydial-specific CD4 Th1 immunity at the genital mucosa. Thus, it is possible that the development of a highly efficacious vaccine against genital infection will depend on the generation of a live attenuated C. trachomatis vaccine. Attenuated strains of C. trachomatis do not exist, so their potential utility as vaccines cannot be tested in animal models of infection. We have developed a surrogate model to study the effect of chlamydial attenuation on infection and immunity of the female genital tract by treating mice with a subchlamydiacidal concentration of oxytetracycline following vaginal infection. Compared to untreated control mice, antibiotic-treated mice shed significantly fewer infectious organisms (3 log(10)) from the cervico-vagina, produced a minimal inflammatory response in urogenital tissue, and did not experience infection-related sequelae. Antibiotic-treated mice generated levels of chlamydia-specific antibody and cell-mediated immunity equivalent to those of control mice. Importantly, antibiotic-treated mice were found to be as immune as control untreated mice when rechallenged vaginally. These findings demonstrate that subclinical chlamydial infection of the murine female genital tract is sufficient to stimulate a potent protective immune response. They also present indirect evidence supporting the possible use of live attenuated chlamydial organisms in the development of vaccines against chlamydial STDs.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047470242

Download citation: RISBibTeXText

PMID: 10603387


Related references

Subclinical Chlamydial Infection of the Female Mouse Genital Tract Generates a Potent Protective Immune Response: Implications for Development of Live Attenuated Chlamydial Vaccine Strains. Infection and Immunity 68(1): 192-196, 2000

Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice. Science in China. Series C, Life Sciences 51(11): 973-980, 2008

Chlamydial serologic characteristics among intrauterine contraceptive device users: Does copper inhibit chlamydial infection in the female genital tract?. American Journal of Obstetrics and Gynecology 171(3): 691-693, 1994

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13(11): 1023-1032, 1995

Characterization of lymphocyte response in the female genital tract during ascending Chlamydial genital infection in the guinea pig model. Infection and Immunity 68(9): 5293-5298, 2000

Chlamydial variants differ in ability to ascend the genital tract in the guinea pig model of chlamydial genital infection. Infection and Immunity 83(8): 3176-3183, 2015

Immune response characteristics in women with chlamydial genital tract infection. Gynecologic and Obstetric Investigation 39(1): 54-59, 1995

Host Nectin-1 Promotes Chlamydial Infection in the Female Mouse Genital Tract, but Is Not Required for Infection in a Novel Male Murine Rectal Infection Model. Plos one 11(8): E0160511, 2016

Chlamydial isolates from the rectum in association with chlamydial infection of the eye or genital tract part 1 laboratory aspects. Nichols, Roger L (Ed ) Excerpta Medica International Congress Series, No 223 Trachoma And Related Disorders Caused By Chlamydial Agents Symposium Xiii+586p Illus Excerpta Medica: Amsterdam, The Netherlands 501-506, 1971

Chlamydial isolates from the rectum in association with chlamydial infection of the eye or genital tract part 2 clinical aspects. Nichols, Roger L (Ed ) Excerpta Medica International Congress Series, No 223 Trachoma And Related Disorders Caused By Chlamydial Agents Symposium Xiii+586p Illus Excerpta Medica: Amsterdam, The Netherlands 507-514, 1971

Does detection of chlamydial antibodies by microimmunofluorescence help in managing chlamydial lower genital tract infection in women?. Genitourinary Medicine 61(3): 172-174, 1985

Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infection and Immunity 39(1): 463-465, 1983

Humoral immune response to chlamydial genital infection of mice with the agent of mouse pneumonitis. Infection and Immunity 57(8): 2441-2446, 1989

Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infection and Immunity 74(12): 6722-6729, 2006

Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infection and Immunity 65(8): 3065-3073, 1997